25 XP   0   0   10

Shandong Xinhua Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Shandong Xinhua Pharmaceutical Co Ltd together

PenkeI guess you are interested in Shandong Xinhua Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shandong Xinhua Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shandong Xinhua Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Xinhua Pharmaceutical Co Ltd.

Quick analysis of Shandong Xinhua Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Shandong Xinhua Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$7.65
Expected worth in 1 year
HK$8.64
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
HK$1.27
Return On Investment
24.0%

For what price can you sell your share?

Current Price per Share
HK$5.29
Expected price per share
HK$4.8600522682446 - HK$5.83
How sure are you?
50%

1. Valuation of Shandong Xinhua Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$5.29

Intrinsic Value Per Share

HK$3.32 - HK$14.15

Total Value Per Share

HK$10.97 - HK$21.80

2. Growth of Shandong Xinhua Pharmaceutical Co Ltd (5 min.)




Is Shandong Xinhua Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$658.8m$566.9m$50.7m8.2%

How much money is Shandong Xinhua Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$17.1m$14.1m$2.9m17.2%
Net Profit Margin6.2%5.5%--

How much money comes from the company's main activities?

3. Financial Health of Shandong Xinhua Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Shandong Xinhua Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Shandong Xinhua Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Shandong Xinhua Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Shandong Xinhua Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Shandong Xinhua Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shandong Xinhua Pharmaceutical Co Ltd is HK$5.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shandong Xinhua Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shandong Xinhua Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$7.65. Based on the TTM, the Book Value Change Per Share is HK$0.25 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shandong Xinhua Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.020.4%0.030.5%0.020.4%0.020.4%0.010.3%
Usd Book Value Change Per Share0.061.1%0.030.6%0.020.4%0.020.3%0.010.3%
Usd Dividend Per Share0.000.0%0.010.2%0.010.2%0.010.1%0.010.1%
Usd Total Gains Per Share0.061.2%0.040.8%0.030.6%0.030.5%0.020.4%
Usd Price Per Share0.74-0.74-0.72-0.60-0.65-
Price to Earnings Ratio8.63-7.44-7.98-7.47-22.61-
Price-to-Total Gains Ratio11.79-86.56-8.07-5.59-18.44-
Price to Book Ratio0.76-0.82-0.85-0.76-1.07-
Price-to-Total Gains Ratio11.79-86.56-8.07-5.59-18.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.675533
Number of shares1480
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.030.02
Usd Total Gains Per Share0.040.03
Gains per Quarter (1480 shares)60.0838.97
Gains per Year (1480 shares)240.32155.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15318723046110146
210637447093219302
3160561710139329458
4213748950185438614
52669351190232548770
631911221430278657926
7373131016703247671082
8426149719103718761238
9479168421504179861394
105321871239046410951550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%80.06.00.093.0%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%15.05.00.075.0%31.09.00.077.5%59.027.00.068.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%84.00.02.097.7%
Total Gains per Share4.00.00.0100.0%9.03.00.075.0%16.04.00.080.0%32.08.00.080.0%65.021.00.075.6%

Fundamentals of Shandong Xinhua Pharmaceutical Co Ltd

About Shandong Xinhua Pharmaceutical Co Ltd

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-15 11:51:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shandong Xinhua Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shandong Xinhua Pharmaceutical Co Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.5% means that $0.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 6.5%. The company is making a profit. +1
  • The TTM is 6.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.5%TTM6.2%+0.3%
TTM6.2%YOY5.5%+0.7%
TTM6.2%5Y5.6%+0.6%
5Y5.6%10Y4.4%+1.1%
1.1.2. Return on Assets

Shows how efficient Shandong Xinhua Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.3% Return on Assets means that Shandong Xinhua Pharmaceutical Co Ltd generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.5%-0.3%
TTM1.5%YOY1.3%+0.3%
TTM1.5%5Y1.3%+0.3%
5Y1.3%10Y1.0%+0.3%
1.1.3. Return on Equity

Shows how efficient Shandong Xinhua Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.3% Return on Equity means Shandong Xinhua Pharmaceutical Co Ltd generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.8%-0.5%
TTM2.8%YOY2.6%+0.2%
TTM2.8%5Y2.6%+0.2%
5Y2.6%10Y2.2%+0.5%

1.2. Operating Efficiency of Shandong Xinhua Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shandong Xinhua Pharmaceutical Co Ltd is operating .

  • Measures how much profit Shandong Xinhua Pharmaceutical Co Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.4%-5.4%
TTM5.4%YOY4.8%+0.6%
TTM5.4%5Y6.0%-0.6%
5Y6.0%10Y4.1%+1.9%
1.2.2. Operating Ratio

Measures how efficient Shandong Xinhua Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are $1.61 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 1.608. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.639. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.608TTM1.639-0.031
TTM1.639YOY1.659-0.020
TTM1.6395Y1.558+0.081
5Y1.55810Y1.269+0.289

1.3. Liquidity of Shandong Xinhua Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shandong Xinhua Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.33 means the company has $1.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 1.333. The company is just able to pay all its short-term debts.
  • The TTM is 1.372. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.333TTM1.372-0.039
TTM1.372YOY1.022+0.350
TTM1.3725Y1.155+0.218
5Y1.15510Y1.110+0.045
1.3.2. Quick Ratio

Measures if Shandong Xinhua Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.28 means the company can pay off $0.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.282. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.737. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.282TTM0.737-0.455
TTM0.737YOY0.638+0.098
TTM0.7375Y0.669+0.067
5Y0.66910Y0.424+0.245

1.4. Solvency of Shandong Xinhua Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shandong Xinhua Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.42 means that Shandong Xinhua Pharmaceutical Co Ltd assets are financed with 42.4% credit (debt) and the remaining percentage (100% - 42.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.424. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.445. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.424TTM0.445-0.021
TTM0.445YOY0.487-0.042
TTM0.4455Y0.498-0.053
5Y0.49810Y0.522-0.024
1.4.2. Debt to Equity Ratio

Measures if Shandong Xinhua Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 77.1% means that company has $0.77 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The MRQ is 0.771. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.812. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.771TTM0.812-0.041
TTM0.812YOY0.988-0.176
TTM0.8125Y1.039-0.227
5Y1.03910Y1.152-0.114

2. Market Valuation of Shandong Xinhua Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Shandong Xinhua Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shandong Xinhua Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 8.63 means the investor is paying $8.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The EOD is 7.900. Based on the earnings, the company is underpriced. +1
  • The MRQ is 8.631. Based on the earnings, the company is underpriced. +1
  • The TTM is 7.445. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.900MRQ8.631-0.732
MRQ8.631TTM7.445+1.187
TTM7.445YOY7.982-0.537
TTM7.4455Y7.468-0.023
5Y7.46810Y22.613-15.146
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The EOD is 12.805. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.991. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -4.537. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.805MRQ13.991-1.186
MRQ13.991TTM-4.537+18.528
TTM-4.537YOY-3.730-0.807
TTM-4.5375Y0.756-5.294
5Y0.75610Y-109.483+110.240
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shandong Xinhua Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shandong Xinhua Pharmaceutical Co Ltd:

  • The EOD is 0.692. Based on the equity, the company is cheap. +2
  • The MRQ is 0.756. Based on the equity, the company is cheap. +2
  • The TTM is 0.815. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.692MRQ0.756-0.064
MRQ0.756TTM0.815-0.059
TTM0.815YOY0.852-0.037
TTM0.8155Y0.762+0.053
5Y0.76210Y1.071-0.309
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shandong Xinhua Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4750.247+92%0.171+177%0.145+228%0.105+353%
Book Value Per Share--7.6487.172+7%6.630+15%6.148+24%5.078+51%
Current Ratio--1.3331.372-3%1.022+30%1.155+15%1.110+20%
Debt To Asset Ratio--0.4240.445-5%0.487-13%0.498-15%0.522-19%
Debt To Equity Ratio--0.7710.812-5%0.988-22%1.039-26%1.152-33%
Dividend Per Share--0.0160.070-78%0.066-76%0.061-74%0.048-67%
Eps--0.1670.199-16%0.180-7%0.160+5%0.112+49%
Free Cash Flow Per Share--0.103-0.024+123%0.207-50%0.048+115%0.050+105%
Free Cash Flow To Equity Per Share--0.103-0.107+204%0.154-33%0.008+1210%0.019+441%
Gross Profit Margin--1.0001.0000%1.0000%-0.029+103%-2.784+378%
Intrinsic Value_10Y_max--14.153--------
Intrinsic Value_10Y_min--3.319--------
Intrinsic Value_1Y_max--0.419--------
Intrinsic Value_1Y_min--0.225--------
Intrinsic Value_3Y_max--2.021--------
Intrinsic Value_3Y_min--0.773--------
Intrinsic Value_5Y_max--4.541--------
Intrinsic Value_5Y_min--1.424--------
Market Cap1031550000.000-278%3899666786.3003933864883.325-1%3781719819.850+3%3044386168.293+28%3145273256.767+24%
Net Profit Margin--0.0650.062+5%0.055+19%0.056+17%0.044+47%
Operating Margin---0.054-100%0.048-100%0.060-100%0.041-100%
Operating Ratio--1.6081.639-2%1.659-3%1.558+3%1.269+27%
Pb Ratio0.692-9%0.7560.815-7%0.852-11%0.762-1%1.071-29%
Pe Ratio7.900-9%8.6317.445+16%7.982+8%7.468+16%22.613-62%
Price Per Share5.290-9%5.7805.833-1%5.648+2%4.707+23%5.074+14%
Price To Free Cash Flow Ratio12.805-9%13.991-4.537+132%-3.730+127%0.756+1749%-109.483+883%
Price To Total Gains Ratio10.786-9%11.78586.556-86%8.066+46%5.585+111%18.441-36%
Quick Ratio--0.2820.737-62%0.638-56%0.669-58%0.424-34%
Return On Assets--0.0130.015-18%0.013-2%0.013-2%0.010+26%
Return On Equity--0.0230.028-18%0.026-12%0.026-13%0.022+6%
Total Gains Per Share--0.4900.318+54%0.237+107%0.206+138%0.153+220%
Usd Book Value--658896735.775617744313.867+7%566977339.576+16%506252919.419+30%402681428.266+64%
Usd Book Value Change Per Share--0.0610.032+92%0.022+177%0.019+228%0.013+353%
Usd Book Value Per Share--0.9770.916+7%0.847+15%0.785+24%0.648+51%
Usd Dividend Per Share--0.0020.009-78%0.008-76%0.008-74%0.006-67%
Usd Eps--0.0210.025-16%0.023-7%0.020+5%0.014+49%
Usd Free Cash Flow--8898245.934-2064484.472+123%17710935.125-50%4037443.868+120%3969185.367+124%
Usd Free Cash Flow Per Share--0.013-0.003+123%0.026-50%0.006+115%0.006+105%
Usd Free Cash Flow To Equity Per Share--0.013-0.014+204%0.020-33%0.001+1210%0.002+441%
Usd Market Cap131728935.000-278%497987448.611502354545.601-1%482925620.995+3%388768113.691+28%401651394.889+24%
Usd Price Per Share0.676-9%0.7380.745-1%0.721+2%0.601+23%0.648+14%
Usd Profit--14423606.72717125584.892-16%14182798.028+2%12976357.236+11%8959460.305+61%
Usd Revenue--221203982.032279412472.431-21%258791305.339-15%232995472.103-5%188672908.763+17%
Usd Total Gains Per Share--0.0630.041+54%0.030+107%0.026+138%0.020+220%
 EOD+4 -4MRQTTM+18 -17YOY+18 -175Y+25 -1110Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of Shandong Xinhua Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.900
Price to Book Ratio (EOD)Between0-10.692
Net Profit Margin (MRQ)Greater than00.065
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.282
Current Ratio (MRQ)Greater than11.333
Debt to Asset Ratio (MRQ)Less than10.424
Debt to Equity Ratio (MRQ)Less than10.771
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.013
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Shandong Xinhua Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.502
Ma 20Greater thanMa 505.327
Ma 50Greater thanMa 1005.441
Ma 100Greater thanMa 2005.513
OpenGreater thanClose5.340
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling General Administrative  382,490135,103517,594-239,113278,48111,993290,474-328,934-38,460



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,286,166
Total Liabilities3,510,413
Total Stockholder Equity4,553,104
 As reported
Total Liabilities 3,510,413
Total Stockholder Equity+ 4,553,104
Total Assets = 8,286,166

Assets

Total Assets8,286,166
Total Current Assets3,314,334
Long-term Assets4,971,833
Total Current Assets
Cash And Cash Equivalents 918,334
Net Receivables 699,878
Inventory 1,312,984
Other Current Assets 89,147
Total Current Assets  (as reported)3,314,334
Total Current Assets  (calculated)3,020,343
+/- 293,991
Long-term Assets
Property Plant Equipment 4,060,814
Intangible Assets 494,937
Long-term Assets Other 102,863
Long-term Assets  (as reported)4,971,833
Long-term Assets  (calculated)4,658,614
+/- 313,218

Liabilities & Shareholders' Equity

Total Current Liabilities2,486,000
Long-term Liabilities1,024,413
Total Stockholder Equity4,553,104
Total Current Liabilities
Short Long Term Debt 283,959
Accounts payable 1,177,843
Other Current Liabilities 22,931
Total Current Liabilities  (as reported)2,486,000
Total Current Liabilities  (calculated)1,484,733
+/- 1,001,268
Long-term Liabilities
Long term Debt 799,400
Capital Lease Obligations Min Short Term Debt1,579
Long-term Liabilities Other 3,562
Long-term Liabilities  (as reported)1,024,413
Long-term Liabilities  (calculated)804,540
+/- 219,872
Total Stockholder Equity
Retained Earnings 2,305,439
Total Stockholder Equity (as reported)4,553,104
Total Stockholder Equity (calculated)2,305,439
+/- 2,247,665
Other
Capital Stock674,683
Common Stock Shares Outstanding 674,683
Net Debt 165,024
Net Invested Capital 5,636,463
Net Working Capital 828,333
Property Plant and Equipment Gross 4,060,814



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-301999-12-311999-06-301998-12-311998-06-301997-12-311997-06-301996-12-31
> Total Assets 
1,212,158
1,223,730
1,217,367
1,258,747
1,300,588
1,393,018
1,384,268
1,467,726
1,362,727
1,423,721
1,836,720
1,885,919
1,871,588
1,897,473
1,905,456
1,971,351
2,027,233
2,132,913
2,085,381
2,256,618
2,394,064
2,358,068
2,298,470
2,292,037
2,406,771
2,295,508
2,207,053
2,223,631
2,047,856
2,159,394
1,880,020
1,993,156
2,040,490
2,005,688
2,270,715
2,172,983
2,131,310
2,290,501
2,161,734
2,323,408
2,404,612
2,497,349
2,626,187
2,753,613
2,796,100
2,841,966
2,739,565
2,818,210
2,852,288
3,089,777
3,004,190
3,430,190
3,398,464
3,578,790
3,628,270
3,718,379
3,625,857
3,675,512
3,849,353
3,837,642
3,931,313
4,119,202
4,245,150
4,349,056
4,489,166
4,439,259
4,492,122
4,506,696
4,387,046
4,599,790
4,722,786
4,847,045
4,997,677
5,168,691
5,273,647
5,422,254
5,671,642
5,742,323
5,916,156
6,040,069
6,096,275
6,049,248
6,436,025
7,044,298
6,795,794
6,695,857
7,092,952
7,279,400
7,271,501
7,189,408
7,332,034
7,674,087
7,946,216
8,194,604
8,265,131
7,976,650
8,075,585
7,921,817
8,286,166
8,286,1667,921,8178,075,5857,976,6508,265,1318,194,6047,946,2167,674,0877,332,0347,189,4087,271,5017,279,4007,092,9526,695,8576,795,7947,044,2986,436,0256,049,2486,096,2756,040,0695,916,1565,742,3235,671,6425,422,2545,273,6475,168,6914,997,6774,847,0454,722,7864,599,7904,387,0464,506,6964,492,1224,439,2594,489,1664,349,0564,245,1504,119,2023,931,3133,837,6423,849,3533,675,5123,625,8573,718,3793,628,2703,578,7903,398,4643,430,1903,004,1903,089,7772,852,2882,818,2102,739,5652,841,9662,796,1002,753,6132,626,1872,497,3492,404,6122,323,4082,161,7342,290,5012,131,3102,172,9832,270,7152,005,6882,040,4901,993,1561,880,0202,159,3942,047,8562,223,6312,207,0532,295,5082,406,7712,292,0372,298,4702,358,0682,394,0642,256,6182,085,3812,132,9132,027,2331,971,3511,905,4561,897,4731,871,5881,885,9191,836,7201,423,7211,362,7271,467,7261,384,2681,393,0181,300,5881,258,7471,217,3671,223,7301,212,158
   > Total Current Assets 
719,942
730,091
705,445
746,072
770,642
831,683
816,777
882,184
762,096
818,284
1,191,355
1,234,116
1,210,315
1,170,430
1,118,431
1,131,763
1,114,279
1,181,810
1,104,742
1,259,733
1,362,628
1,177,923
1,113,741
1,115,287
1,219,241
1,115,504
1,041,049
1,069,476
891,163
996,610
738,616
872,132
920,415
862,044
849,271
902,098
891,523
1,026,449
883,649
995,584
1,004,242
1,050,817
1,060,655
1,139,706
1,217,221
1,274,474
1,159,499
1,235,126
1,187,480
1,350,108
1,141,043
1,477,548
1,334,755
1,426,492
1,399,867
1,462,394
1,297,653
1,290,322
1,392,887
1,346,820
1,395,339
1,512,291
1,462,415
1,595,954
1,744,569
1,700,342
1,651,479
1,680,741
1,518,611
1,689,441
1,710,589
1,823,140
1,861,640
1,960,374
2,009,989
2,145,669
2,303,286
2,299,425
2,349,165
2,329,699
2,303,166
2,154,327
2,428,387
3,094,025
2,810,806
2,587,306
2,686,871
2,851,445
2,848,432
2,694,392
2,753,958
3,055,125
3,287,926
3,464,395
3,456,959
3,136,311
3,235,189
3,026,216
3,314,334
3,314,3343,026,2163,235,1893,136,3113,456,9593,464,3953,287,9263,055,1252,753,9582,694,3922,848,4322,851,4452,686,8712,587,3062,810,8063,094,0252,428,3872,154,3272,303,1662,329,6992,349,1652,299,4252,303,2862,145,6692,009,9891,960,3741,861,6401,823,1401,710,5891,689,4411,518,6111,680,7411,651,4791,700,3421,744,5691,595,9541,462,4151,512,2911,395,3391,346,8201,392,8871,290,3221,297,6531,462,3941,399,8671,426,4921,334,7551,477,5481,141,0431,350,1081,187,4801,235,1261,159,4991,274,4741,217,2211,139,7061,060,6551,050,8171,004,242995,584883,6491,026,449891,523902,098849,271862,044920,415872,132738,616996,610891,1631,069,4761,041,0491,115,5041,219,2411,115,2871,113,7411,177,9231,362,6281,259,7331,104,7421,181,8101,114,2791,131,7631,118,4311,170,4301,210,3151,234,1161,191,355818,284762,096882,184816,777831,683770,642746,072705,445730,091719,942
       Cash And Cash Equivalents 
306,450
0
228,241
249,743
51
311,355
289,649
343,971
279,226
308,942
617,030
607,853
578,411
534,456
503,467
452,681
429,978
448,329
413,986
462,468
497,288
333,986
337,933
279,108
430,538
346,667
363,191
326,708
229,945
330,550
162,535
200,087
238,890
191,271
212,258
169,302
205,851
315,314
238,124
253,727
310,046
250,415
401,894
402,973
486,246
494,717
404,050
387,079
371,374
432,460
299,229
530,937
394,346
455,092
422,144
373,654
213,385
196,626
380,722
266,387
253,798
391,322
328,769
303,143
506,048
521,396
476,289
449,937
403,203
608,187
561,332
543,195
575,212
794,835
731,126
735,395
904,876
838,859
778,423
648,311
661,965
628,762
690,470
1,335,553
1,114,374
949,279
855,771
913,617
948,752
817,890
596,339
952,052
1,110,710
1,212,767
1,010,764
863,701
854,300
824,282
918,334
918,334824,282854,300863,7011,010,7641,212,7671,110,710952,052596,339817,890948,752913,617855,771949,2791,114,3741,335,553690,470628,762661,965648,311778,423838,859904,876735,395731,126794,835575,212543,195561,332608,187403,203449,937476,289521,396506,048303,143328,769391,322253,798266,387380,722196,626213,385373,654422,144455,092394,346530,937299,229432,460371,374387,079404,050494,717486,246402,973401,894250,415310,046253,727238,124315,314205,851169,302212,258191,271238,890200,087162,535330,550229,945326,708363,191346,667430,538279,108337,933333,986497,288462,468413,986448,329429,978452,681503,467534,456578,411607,853617,030308,942279,226343,971289,649311,35551249,743228,2410306,450
       Short-term Investments 
0
0
0
0
261,618
0
0
0
0
0
0
0
0
0
0
0
0
30,004
31,178
51,178
70,000
70,000
58,551
58,551
58,039
58,060
0
0
0
0
0
349
2,095
2,008
15,897
16,976
2,262
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000030,0000000000000000000000000000000000002,26216,97615,8972,0082,0953490000058,06058,03958,55158,55170,00070,00051,17831,17830,004000000000000261,6180000
       Net Receivables 
0
0
0
0
0
0
0
0
0
319,862
373,211
0
424,281
0
390,784
0
454,968
0
422,330
0
540,124
0
428,147
0
494,527
0
0
0
413,980
0
349,881
0
418,061
0
313,637
0
386,334
0
305,145
0
403,918
0
288,962
0
391,134
0
319,415
0
408,796
0
369,973
0
455,381
0
400,781
0
575,974
0
437,855
0
660,794
0
481,486
0
677,041
0
583,796
0
643,116
0
496,988
0
748,440
0
480,889
0
652,543
0
513,532
646,180
594,976
549,632
474,908
851,234
782,407
694,478
543,711
894,491
971,176
841,186
887,871
1,136,946
1,074,590
1,187,285
762,981
1,209,136
1,175,857
1,093,760
699,878
699,8781,093,7601,175,8571,209,136762,9811,187,2851,074,5901,136,946887,871841,186971,176894,491543,711694,478782,407851,234474,908549,632594,976646,180513,5320652,5430480,8890748,4400496,9880643,1160583,7960677,0410481,4860660,7940437,8550575,9740400,7810455,3810369,9730408,7960319,4150391,1340288,9620403,9180305,1450386,3340313,6370418,0610349,8810413,980000494,5270428,1470540,1240422,3300454,9680390,7840424,2810373,211319,862000000000
       Inventory 
184,378
0
198,313
176,773
180,311
173,496
179,517
161,217
166,122
178,241
197,590
206,379
204,412
205,608
220,777
216,335
225,465
229,169
250,538
240,561
255,434
257,635
300,253
265,558
238,677
219,748
274,765
253,536
242,799
214,014
224,355
207,019
222,163
216,383
286,041
255,076
270,274
290,234
304,514
264,428
245,777
252,559
344,219
308,483
309,061
280,464
401,543
340,279
370,244
385,959
423,789
412,429
445,934
436,779
489,673
531,541
490,557
513,126
531,992
463,942
425,935
480,860
588,888
532,319
503,338
490,475
546,460
451,658
443,218
392,965
559,487
469,737
499,816
468,262
713,211
592,533
670,638
657,272
951,723
793,252
782,749
753,606
1,130,343
810,173
788,306
818,818
1,124,364
914,867
844,467
901,656
1,027,540
846,589
1,035,132
970,173
1,211,987
969,460
1,010,804
970,748
1,312,984
1,312,984970,7481,010,804969,4601,211,987970,1731,035,132846,5891,027,540901,656844,467914,8671,124,364818,818788,306810,1731,130,343753,606782,749793,252951,723657,272670,638592,533713,211468,262499,816469,737559,487392,965443,218451,658546,460490,475503,338532,319588,888480,860425,935463,942531,992513,126490,557531,541489,673436,779445,934412,429423,789385,959370,244340,279401,543280,464309,061308,483344,219252,559245,777264,428304,514290,234270,274255,076286,041216,383222,163207,019224,355214,014242,799253,536274,765219,748238,677265,558300,253257,635255,434240,561250,538229,169225,465216,335220,777205,608204,412206,379197,590178,241166,122161,217179,517173,496180,311176,773198,3130184,378
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,710,370
3,793,109
3,894,921
4,007,638
3,950,274
3,984,988
4,108,551
4,406,081
4,427,955
4,423,069
4,495,016
4,578,075
4,618,962
4,658,290
4,730,209
4,808,172
4,840,339
4,840,395
4,895,601
4,971,833
4,971,8334,895,6014,840,3954,840,3394,808,1724,730,2094,658,2904,618,9624,578,0754,495,0164,423,0694,427,9554,406,0814,108,5513,984,9883,950,2744,007,6383,894,9213,793,1093,710,3700000000000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
423,528
425,634
444,598
446,033
463,987
496,057
502,076
487,624
499,652
573,903
595,816
524,650
605,182
603,174
730,970
707,858
776,789
803,173
900,056
846,928
735,063
890,864
700,194
883,833
757,363
892,192
897,561
887,073
777,783
886,151
779,316
897,022
885,369
895,378
924,444
929,340
949,958
987,723
1,044,060
1,054,582
1,078,912
1,058,136
1,095,906
1,110,535
1,115,546
1,115,397
1,125,624
1,126,828
1,209,246
1,310,640
1,426,486
1,492,430
1,590,997
1,694,364
1,696,963
1,745,295
1,841,006
1,873,231
1,946,378
1,996,436
2,036,455
2,062,972
2,153,726
2,105,275
2,105,427
2,162,446
2,225,751
2,235,561
2,278,703
2,315,602
2,395,416
2,405,926
2,468,968
2,534,611
2,587,451
2,639,302
2,744,979
2,800,148
2,884,364
2,934,538
3,011,397
3,075,982
3,200,977
3,209,612
3,251,869
3,362,468
3,538,852
3,564,662
3,603,530
3,697,596
3,765,724
3,822,232
3,856,466
3,944,631
4,000,465
3,995,824
3,982,792
3,991,290
4,060,814
4,060,8143,991,2903,982,7923,995,8244,000,4653,944,6313,856,4663,822,2323,765,7243,697,5963,603,5303,564,6623,538,8523,362,4683,251,8693,209,6123,200,9773,075,9823,011,3972,934,5382,884,3642,800,1482,744,9792,639,3022,587,4512,534,6112,468,9682,405,9262,395,4162,315,6022,278,7032,235,5612,225,7512,162,4462,105,4272,105,2752,153,7262,062,9722,036,4551,996,4361,946,3781,873,2311,841,0061,745,2951,696,9631,694,3641,590,9971,492,4301,426,4861,310,6401,209,2461,126,8281,125,6241,115,3971,115,5461,110,5351,095,9061,058,1361,078,9121,054,5821,044,060987,723949,958929,340924,444895,378885,369897,022779,316886,151777,783887,073897,561892,192757,363883,833700,194890,864735,063846,928900,056803,173776,789707,858730,970603,174605,182524,650595,816573,903499,652487,624502,076496,057463,987446,033444,598425,634423,528
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,716
2,716
2,716
2,716
2,716
2,716
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000002,7162,7162,7162,7162,7162,716000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189,475
0
223,180
0
258,141
0
206,428
0
209,334
0
316,120
0
296,248
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000296,2480316,1200209,3340206,4280258,1410223,1800189,4750000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
67,188
0
65,824
65,141
64,459
63,777
0
63,011
62,315
61,619
69,075
69,436
68,977
68,517
68,331
68,100
72,534
71,427
70,443
69,773
74,862
74,097
72,169
98,881
98,174
97,532
97,311
96,293
95,275
94,257
93,301
93,439
92,577
91,644
96,647
99,834
100,742
111,037
110,738
109,603
108,553
180,511
198,530
233,174
231,757
230,230
228,721
227,248
225,792
229,626
223,504
230,643
243,619
241,182
257,879
260,205
257,655
272,874
271,002
268,298
265,494
299,061
312,962
306,439
302,105
299,117
294,565
291,485
288,465
285,416
283,275
280,731
344,328
336,432
323,563
321,451
319,921
317,721
332,704
331,561
357,083
410,398
411,594
415,346
412,882
410,514
449,247
446,187
454,185
450,530
466,451
473,094
480,911
475,203
474,107
467,721
463,365
464,921
494,937
494,937464,921463,365467,721474,107475,203480,911473,094466,451450,530454,185446,187449,247410,514412,882415,346411,594410,398357,083331,561332,704317,721319,921321,451323,563336,432344,328280,731283,275285,416288,465291,485294,565299,117302,105306,439312,962299,061265,494268,298271,002272,874257,655260,205257,879241,182243,619230,643223,504229,626225,792227,248228,721230,230231,757233,174198,530180,511108,553109,603110,738111,037100,74299,83496,64791,64492,57793,43993,30194,25795,27596,29397,31197,53298,17498,88172,16974,09774,86269,77370,44371,42772,53468,10068,33168,51768,97769,43669,07561,61962,31563,011063,77764,45965,14165,824067,188
       Other Assets 
0
0
0
0
0
0
0
0
0
38,500
55,277
0
56,091
0
56,056
0
136,165
0
84,328
0
515,627
0
488,536
0
565,908
0
0
0
384,480
0
241,735
0
234,706
0
497,000
0
289,829
0
234,025
0
321,457
0
469,626
0
463,333
0
454,441
0
455,562
0
436,661
0
472,712
0
531,441
0
578,201
0
510,089
0
499,519
0
629,009
0
639,170
0
614,893
0
589,733
0
616,781
0
667,070
0
676,206
0
97,028
0
140,589
71,566
31,319
34,856
98,818
82,696
83,294
83,811
101,364
97,726
91,838
89,645
85,702
80,182
73,016
81,665
94,416
127,491
141,392
172,420
0
0172,420141,392127,49194,41681,66573,01680,18285,70289,64591,83897,726101,36483,81183,29482,69698,81834,85631,31971,566140,589097,0280676,2060667,0700616,7810589,7330614,8930639,1700629,0090499,5190510,0890578,2010531,4410472,7120436,6610455,5620454,4410463,3330469,6260321,4570234,0250289,8290497,0000234,7060241,7350384,480000565,9080488,5360515,627084,3280136,165056,056056,091055,27738,500000000000
> Total Liabilities 
500,895
463,508
411,523
414,374
450,683
503,439
493,333
533,311
436,815
447,710
495,925
521,172
490,492
500,897
523,110
565,174
601,514
700,957
668,108
821,971
968,015
928,790
955,560
940,218
1,048,637
934,104
862,469
869,285
710,624
818,161
533,371
607,833
585,903
529,624
553,961
578,220
608,899
781,152
674,736
782,108
816,609
891,124
956,224
1,052,232
1,123,009
1,141,183
1,025,031
1,076,505
1,099,622
1,337,639
1,254,451
1,661,834
1,616,091
1,808,782
1,851,281
1,968,794
1,881,752
1,892,927
2,052,533
2,049,014
2,103,900
2,273,477
2,333,281
2,416,411
2,548,535
2,508,652
2,508,040
2,533,172
2,389,857
2,548,505
2,643,479
2,712,930
2,776,657
2,866,742
2,694,194
2,806,161
2,994,520
2,971,925
3,119,603
3,133,317
3,161,684
3,030,939
3,325,495
3,878,547
3,642,977
3,452,026
3,701,662
3,744,102
3,747,287
3,601,189
3,864,092
3,627,144
3,874,926
4,001,251
4,138,671
3,652,688
3,744,770
3,442,442
3,510,413
3,510,4133,442,4423,744,7703,652,6884,138,6714,001,2513,874,9263,627,1443,864,0923,601,1893,747,2873,744,1023,701,6623,452,0263,642,9773,878,5473,325,4953,030,9393,161,6843,133,3173,119,6032,971,9252,994,5202,806,1612,694,1942,866,7422,776,6572,712,9302,643,4792,548,5052,389,8572,533,1722,508,0402,508,6522,548,5352,416,4112,333,2812,273,4772,103,9002,049,0142,052,5331,892,9271,881,7521,968,7941,851,2811,808,7821,616,0911,661,8341,254,4511,337,6391,099,6221,076,5051,025,0311,141,1831,123,0091,052,232956,224891,124816,609782,108674,736781,152608,899578,220553,961529,624585,903607,833533,371818,161710,624869,285862,469934,1041,048,637940,218955,560928,790968,015821,971668,108700,957601,514565,174523,110500,897490,492521,172495,925447,710436,815533,311493,333503,439450,683414,374411,523463,508500,895
   > Total Current Liabilities 
395,523
351,816
302,163
305,013
336,743
471,506
489,772
529,750
433,253
444,149
342,364
367,610
286,931
297,335
519,549
561,613
597,953
497,395
464,547
618,410
714,454
675,228
951,999
936,656
1,045,076
930,542
858,907
865,724
707,063
814,600
529,809
604,272
582,341
526,062
496,604
544,546
585,361
761,667
670,525
770,850
738,148
728,505
622,325
638,640
715,282
658,661
689,634
641,866
645,267
874,350
972,157
782,767
745,069
1,007,026
1,020,426
915,811
937,095
924,873
1,025,854
821,784
888,477
1,243,055
1,601,090
1,690,440
1,706,955
1,495,331
1,950,916
2,033,864
1,830,501
2,173,618
2,270,507
2,353,728
1,802,450
1,621,203
1,490,839
1,616,410
2,118,438
2,214,053
2,360,045
2,351,982
2,264,546
2,112,565
2,485,514
2,481,573
2,291,818
2,116,568
2,381,039
2,150,163
2,507,368
2,400,801
2,501,880
3,322,627
3,286,848
3,221,776
3,158,486
2,136,890
2,482,219
2,185,532
2,486,000
2,486,0002,185,5322,482,2192,136,8903,158,4863,221,7763,286,8483,322,6272,501,8802,400,8012,507,3682,150,1632,381,0392,116,5682,291,8182,481,5732,485,5142,112,5652,264,5462,351,9822,360,0452,214,0532,118,4381,616,4101,490,8391,621,2031,802,4502,353,7282,270,5072,173,6181,830,5012,033,8641,950,9161,495,3311,706,9551,690,4401,601,0901,243,055888,477821,7841,025,854924,873937,095915,8111,020,4261,007,026745,069782,767972,157874,350645,267641,866689,634658,661715,282638,640622,325728,505738,148770,850670,525761,667585,361544,546496,604526,062582,341604,272529,809814,600707,063865,724858,907930,5421,045,076936,656951,999675,228714,454618,410464,547497,395597,953561,613519,549297,335286,931367,610342,364444,149433,253529,750489,772471,506336,743305,013302,163351,816395,523
       Short-term Debt 
167,044
0
145,591
176,230
190,630
245,230
276,230
305,500
259,100
299,300
182,100
167,100
130,000
130,000
140,000
130,000
130,000
202,771
174,156
275,145
352,803
306,083
306,285
280,616
400,816
532,201
418,969
416,717
352,225
461,605
235,234
229,497
128,718
98,417
206,819
220,874
245,144
376,146
284,475
304,102
279,064
254,132
124,024
73,961
93,620
67,270
50,000
50,000
50,000
200,000
296,147
197,752
190,000
340,000
419,855
357,000
162,354
266,593
330,666
179,163
287,516
457,450
429,979
462,524
470,928
452,698
530,000
530,000
430,000
460,000
910,000
1,010,000
614,000
370,000
151,838
236,336
235,835
235,334
235,000
200,000
340,000
540,000
540,000
560,000
230,000
70,000
200,420
308,774
708,624
780,913
710,384
862,940
938,657
930,019
621,377
756,667
721,333
708,409
0
0708,409721,333756,667621,377930,019938,657862,940710,384780,913708,624308,774200,42070,000230,000560,000540,000540,000340,000200,000235,000235,334235,835236,336151,838370,000614,0001,010,000910,000460,000430,000530,000530,000452,698470,928462,524429,979457,450287,516179,163330,666266,593162,354357,000419,855340,000190,000197,752296,147200,00050,00050,00050,00067,27093,62073,961124,024254,132279,064304,102284,475376,146245,144220,874206,81998,417128,718229,497235,234461,605352,225416,717418,969532,201400,816280,616306,285306,083352,803275,145174,156202,771130,000130,000140,000130,000130,000167,100182,100299,300259,100305,500276,230245,230190,630176,230145,5910167,044
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,419,793
0
1,614,296
0
6,000
0
376,000
0
526,000
200,000
340,000
540,000
540,000
560,000
230,000
70,000
200,420
308,774
331,074
330,363
269,455
340,025
369,070
382,449
118,023
233,128
243,495
269,316
283,959
283,959269,316243,495233,128118,023382,449369,070340,025269,455330,363331,074308,774200,42070,000230,000560,000540,000540,000340,000200,000526,0000376,00006,00001,614,29601,419,7930000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
100,044
85,734
0
109,212
0
116,878
0
199,087
0
237,547
0
276,555
0
307,769
0
305,616
0
0
0
264,542
0
213,080
0
331,806
0
184,285
0
232,431
0
255,090
0
298,443
0
283,962
0
395,833
0
334,245
0
289,470
0
358,155
0
414,712
0
396,429
0
429,659
0
358,860
0
394,773
0
483,278
0
531,316
0
596,436
0
452,192
0
687,194
0
602,915
0
738,293
0
889,668
0
889,607
917,603
838,491
762,791
798,512
780,110
682,450
623,943
742,903
875,047
905,554
950,219
1,066,391
1,057,736
1,199,783
1,220,398
1,090,080
1,086,236
1,150,295
969,969
1,177,843
1,177,843969,9691,150,2951,086,2361,090,0801,220,3981,199,7831,057,7361,066,391950,219905,554875,047742,903623,943682,450780,110798,512762,791838,491917,603889,6070889,6680738,2930602,9150687,1940452,1920596,4360531,3160483,2780394,7730358,8600429,6590396,4290414,7120358,1550289,4700334,2450395,8330283,9620298,4430255,0900232,4310184,2850331,8060213,0800264,542000305,6160307,7690276,5550237,5470199,0870116,8780109,212085,734100,044000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
32,990
32,290
0
47,718
0
52,126
0
68,866
0
47,235
0
64,635
0
77,627
0
64,848
0
0
0
67,738
0
56,587
0
121,817
0
105,500
0
107,785
0
130,961
0
160,641
0
214,338
0
225,830
0
155,389
0
155,798
0
138,855
0
140,357
0
130,627
0
171,024
0
191,329
0
206,188
0
278,925
0
268,876
0
238,935
0
284,993
0
328,459
0
336,068
0
511,087
0
480,595
0
519,176
769,057
563,539
431,342
685,617
695,446
722,997
831,863
934,742
804,517
714,910
642,118
653,510
586,593
1,283,164
1,565,261
85,810
654,500
601,522
581,333
22,931
22,931581,333601,522654,50085,8101,565,2611,283,164586,593653,510642,118714,910804,517934,742831,863722,997695,446685,617431,342563,539769,057519,1760480,5950511,0870336,0680328,4590284,9930238,9350268,8760278,9250206,1880191,3290171,0240130,6270140,3570138,8550155,7980155,3890225,8300214,3380160,6410130,9610107,7850105,5000121,817056,587067,73800064,848077,627064,635047,235068,866052,126047,718032,29032,990000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
781,334
897,139
918,374
839,981
1,396,974
1,351,159
1,335,458
1,320,623
1,593,939
1,239,918
1,200,388
1,179,008
304,516
588,078
779,475
756,741
1,290,128
1,043,187
1,035,178
1,024,413
1,024,4131,035,1781,043,1871,290,128756,741779,475588,078304,5161,179,0081,200,3881,239,9181,593,9391,320,6231,335,4581,351,1591,396,974839,981918,374897,139781,3340000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
554,160
704,793
693,024
640,922
539,179
0
0
0
0
985,314
358,886
952,967
69,254
375,672
561,018
548,371
1,049,482
807,058
802,629
0
0802,629807,0581,049,482548,371561,018375,67269,254952,967358,886985,3140000539,179640,922693,024704,793554,1600000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,562
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,562
0
3,562
0
3,562
0
3,562
0
3,562
0
54,218
0
53,923
0
58,710
0
58,562
0
64,824
0
75,209
0
102,078
0
135,793
0
131,900
0
142,178
0
81,245
0
131,750
0
116,891
0
119,624
0
206,839
0
218,066
0
207,223
0
234,623
0
170,011
0
192,345
184,017
199,059
207,640
216,891
208,916
233,953
228,452
254,604
207,689
226,041
208,061
212,406
198,457
208,369
240,646
236,128
232,549
0
0232,549236,128240,646208,369198,457212,406208,061226,041207,689254,604228,452233,953208,916216,891207,640199,059184,017192,3450170,0110234,6230207,2230218,0660206,8390119,6240116,8910131,750081,2450142,1780131,9000135,7930102,078075,209064,824058,562058,710053,923054,21803,56203,56203,56203,56203,562000000000000000003,56200000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,916
11,300
10,684
10,067
10,541
9,870
9,199
8,528
8,608
7,896
7,224
15,072
0
015,0727,2247,8968,6088,5289,1999,87010,54110,06710,68411,30011,91600000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
983,076
1,384,816
0
1,379,850
0
1,379,669
0
1,423,022
0
1,438,776
0
1,444,256
0
1,369,322
0
1,382,844
0
0
0
1,358,830
0
1,369,144
0
1,429,101
0
1,665,961
0
1,492,679
0
1,453,253
0
1,554,427
0
1,633,646
0
1,637,660
0
1,676,524
0
1,713,019
0
1,709,932
0
1,740,887
0
1,737,288
0
1,709,716
0
1,759,530
0
1,787,462
0
1,820,690
0
1,838,670
0
1,884,257
0
1,907,714
0
1,988,420
0
2,124,047
0
2,480,024
0
2,535,826
0
2,687,248
2,791,190
2,813,417
2,893,341
2,969,028
3,016,471
3,023,506
3,110,751
3,223,794
3,359,487
3,330,193
3,406,442
3,467,942
3,848,478
3,876,385
3,972,803
4,126,460
4,323,962
4,330,815
4,479,375
4,553,104
4,553,1044,479,3754,330,8154,323,9624,126,4603,972,8033,876,3853,848,4783,467,9423,406,4423,330,1933,359,4873,223,7943,110,7513,023,5063,016,4712,969,0282,893,3412,813,4172,791,1902,687,24802,535,82602,480,02402,124,04701,988,42001,907,71401,884,25701,838,67001,820,69001,787,46201,759,53001,709,71601,737,28801,740,88701,709,93201,713,01901,676,52401,637,66001,633,64601,554,42701,453,25301,492,67901,665,96101,429,10101,369,14401,358,8300001,382,84401,369,32201,444,25601,438,77601,423,02201,379,66901,379,85001,384,816983,076000000000
   Common Stock
0
0
0
0
0
0
0
0
0
427,313
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
0
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
457,313
0
478,353
0
478,353
0
621,859
621,859
621,859
621,859
621,859
621,859
621,859
621,859
621,859
627,367
627,367
627,367
627,367
669,627
669,627
669,627
669,627
673,888
674,683
674,683
0
0674,683674,683673,888669,627669,627669,627669,627627,367627,367627,367627,367621,859621,859621,859621,859621,859621,859621,859621,859621,8590478,3530478,3530457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,313000457,3130457,3130457,3130457,3130457,3130457,3130457,3130457,313427,313000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000-2,435,6950-2,251,2140-2,097,9000-1,944,9130-1,868,5080-1,761,0880-1,703,5620-1,586,8340-1,492,0950-1,378,7490-1,309,9160-1,211,6000-1,370,2290-1,303,6650-1,289,1360-1,208,5820-1,140,6670-1,112,3600-1,063,5570-1,006,8850-1,003,8960-948,1780-973,1670-961,4450-970,3010-926,2930-902,4780-17,86000000-14,1970-12,965000-11,139000-9,4890-8,6670-7,8440000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
624,907
626,998
629,089
634,143
636,234
636,098
638,189
644,907
672,232
675,416
676,523
677,941
920,638
958,220
969,819
998,145
1,030,826
1,048,054
1,061,735
0
01,061,7351,048,0541,030,826998,145969,819958,220920,638677,941676,523675,416672,232644,907638,189636,098636,234634,143629,089626,998624,9070000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,421
0
168,273
0
199,385
0
155,741
0
142,645
169,051
179,343
168,525
183,445
142,510
139,394
150,793
177,211
179,795
141,615
131,504
128,373
115,449
120,332
106,097
113,679
122,634
128,197
140,915
0
0140,915128,197122,634113,679106,097120,332115,449128,373131,504141,615179,795177,211150,793139,394142,510183,445168,525179,343169,051142,6450155,7410199,3850168,2730139,4210000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,100,845
Cost of Revenue-5,709,142
Gross Profit2,391,7022,391,702
 
Operating Income (+$)
Gross Profit2,391,702
Operating Expense-7,488,651
Operating Income612,193-5,096,949
 
Operating Expense (+$)
Research Development419,240
Selling General Administrative967,005
Selling And Marketing Expenses0
Operating Expense7,488,6511,386,245
 
Net Interest Income (+$)
Interest Income12,300
Interest Expense-41,149
Other Finance Cost-2,924
Net Interest Income-31,772
 
Pretax Income (+$)
Operating Income612,193
Net Interest Income-31,772
Other Non-Operating Income Expenses0
Income Before Tax (EBT)532,686612,193
EBIT - interestExpense = -41,149
496,512
537,661
Interest Expense41,149
Earnings Before Interest and Taxes (EBIT)0573,834
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax532,686
Tax Provision-26,579
Net Income From Continuing Ops506,107506,107
Net Income496,512
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net031,772
 

Technical Analysis of Shandong Xinhua Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shandong Xinhua Pharmaceutical Co Ltd. The general trend of Shandong Xinhua Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shandong Xinhua Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shandong Xinhua Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.49 < 5.8 < 5.83.

The bearish price targets are: 5.22 > 5.22 > 4.8600522682446.

Tweet this
Shandong Xinhua Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shandong Xinhua Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shandong Xinhua Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shandong Xinhua Pharmaceutical Co Ltd. The current macd is -0.04777025.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shandong Xinhua Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shandong Xinhua Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shandong Xinhua Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shandong Xinhua Pharmaceutical Co Ltd. The current adx is 13.42.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shandong Xinhua Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Shandong Xinhua Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shandong Xinhua Pharmaceutical Co Ltd. The current sar is 5.3676225.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shandong Xinhua Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shandong Xinhua Pharmaceutical Co Ltd. The current rsi is 44.50. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shandong Xinhua Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shandong Xinhua Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShandong Xinhua Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shandong Xinhua Pharmaceutical Co Ltd. The current cci is -48.32214765.

Shandong Xinhua Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shandong Xinhua Pharmaceutical Co Ltd. The current cmo is -11.5922346.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shandong Xinhua Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shandong Xinhua Pharmaceutical Co Ltd. The current willr is -74.07407407.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shandong Xinhua Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shandong Xinhua Pharmaceutical Co Ltd Daily Williams %R ChartShandong Xinhua Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shandong Xinhua Pharmaceutical Co Ltd.

Shandong Xinhua Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shandong Xinhua Pharmaceutical Co Ltd. The current atr is 0.11264858.

Shandong Xinhua Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shandong Xinhua Pharmaceutical Co Ltd. The current obv is 584,519,366.

Shandong Xinhua Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShandong Xinhua Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shandong Xinhua Pharmaceutical Co Ltd. The current mfi is 60.55.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shandong Xinhua Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShandong Xinhua Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shandong Xinhua Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Shandong Xinhua Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shandong Xinhua Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.502
Ma 20Greater thanMa 505.327
Ma 50Greater thanMa 1005.441
Ma 100Greater thanMa 2005.513
OpenGreater thanClose5.340
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shandong Xinhua Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shandong Xinhua Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shandong Xinhua Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shandong Xinhua Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Xinhua Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shandong Xinhua Pharmaceutical Co Ltd.

Receive notifications about Shandong Xinhua Pharmaceutical Co Ltd in your mailbox!